PRG4 and hepatocellular carcinoma: Combining the relationship between PRG4 expression and clinical characteristics and prognosis of patients with HCC receiving TACE, it was found that PRG4 seems to affect the prognosis of patients by affecting the metastasis and migration of HCC, which means that the prognosis of HCC patients with high PRG4 expression after TACE is better.